prostate cancer
Conditions
Interventions
Patients with suspected prostate cancer undergoing prostate biopsy:none
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Inclusion Criteria for Prostate Cancer and Biopsy-Negative Patients1) Male, aged <= 85 years;2) Patients undergoing prostate biopsy for definitive diagnosis due to elevated PSA, positive digital rectal exam, or imaging indicative of suspected prostate cancer.Outpatients or inpatients who meet all of the above criteria and have collected pre-treatment urine samples can be included as subjects. Outpatients or inpatients who meet all of the above criteria and have collected urine samples can be included as subjects.
Exclusion criteria
Exclusion criteria: 1) Patients diagnosed with any malignant tumor within the past 5 years; 2) Patients who have previously undergone transurethral resection or ablation of the prostate; 3) Patients who have had prostate biopsies due to suspected prostate cancer; 4) Patients who have been on long-term anticoagulant or antiplatelet aggregation therapy (with anticoagulants stopped for less than 1 week); 5) Patients who have received any form of tumor treatment, including surgery, radiotherapy/chemotherapy, endocrine therapy, targeted therapy, and immunotherapy, within one month prior to blood draw for enrollment; 6) Patients with other severe systemic diseases that the investigator believes may interfere with the treatment, evaluation, and adherence of this trial, including severe respiratory, circulatory, neurological, psychiatric, digestive, endocrine, immune, and urinary system diseases; 7) Organ transplant recipients or those who have previously undergone non-autologous (allogeneic) bone marrow or stem cell transplants; 8) Subjects who had a blood transfusion within one month prior to blood draw; 9) Patients who are participating in other clinical trials, or who have participated in other clinical trials and completed them less than one year ago; 10) Patients whom the investigator deems unsuitable to participate in this clinical trial; any patient who meets any of the above criteria cannot be included as a subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ROC value;Specificity; | — |
Countries
China
Contacts
Public ContactDi Gu
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed